The Coronavirus Outbreak

New unpublished studies show that dogs and cats with COVID-positive owners frequently have SARS-CoV-2 antibodies

Today we bring you a new episode in our podcast series: COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.

You can listen to all past episodes here.

Children can suffer lingering symptoms from the disease, but researchers are still working to determine how frequently and how severely

Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort

Workers are anxious because the coronavirus is still infecting people. Here are ways to evaluate the safety of a shared work space

Current prevention measures may not be enough to prevent an outbreak

Studies suggest mixing vaccines provokes potent immune responses, but scientists want answers on real-world efficacy and rare side effects

In both cases, harm reduction is a better strategy than draconian rules that feel virtuous but don’t actually work

Amid a COVID surge in Africa, vaccine promises from richer nations are not enough to bring an early end to the pandemic, experts say

We need to plan for a future where millions of survivors are chronically ill

Today we bring you a new episode in our podcast series: COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.

Researchers have begun to crack the code of protein structure, allowing them to remake, well, everything